- Home
- PLRX vs CIRC Comparison
PLRX vs CIRC Comparison
Compare PLRX & CIRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.06
Company Overview
Basic Information| Metric | PLRX | CIRC |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 65.6M | 67.3M |
| IPO Year | 2020 | 2024 |
Fundamental Metrics
Financial Performance| Metric | PLRX | CIRC |
|---|---|---|
| Price | $1.06 | $0.74 |
| Analyst Decision | Hold | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $2.67 | N/A |
| AVG Volume (30 Days) | 633.2K | ★ 5.5M |
| Earning Date | 05-06-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.97 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.03 | $0.55 |
| 52 Week High | $1.95 | $0.98 |
Technical Indicators
Market Signals| Indicator | PLRX | CIRC |
|---|---|---|
| Relative Strength Index (RSI) | 39.26 | 54.07 |
| Support Level | N/A | $0.62 |
| Resistance Level | $1.37 | $0.83 |
| Average True Range (ATR) | 0.04 | 0.07 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 17.39 | 76.99 |
Price Performance
Historical Comparison PLRX
CIRC
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.